Icon Plc (NASDAQ:ICLR) is one of the 782 companies in the GICS Health Care sector, and a member of the 31 company Life Sciences Tools & Services GICS industry group within this sector. The market value of ICLR is $6.3 billion which falls in the top half of its industry group. The stock's current Portfolio Grader score places it 3 among the 31 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 32 among the 782 companies in the sector, and number 192 in the nearly 5,000 company Portfolio Grader universe.

With a $6.3 billion market value, Icon Plc (NASDAQ:ICLR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top quarter of its sector group, Health Care, in market value. From the prospective of investment attractiveness, the stock's Portfolio Grader ranking places it 4 among the 31 companies in this industry group, placing it among the leaders; among the sector leaders with a ranking of 35 among the 781 companies in the sector, and number 215 in the nearly 5,000 company Portfolio Grader universe.

Icon Plc (NASDAQ:ICLR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top 25% of its sector group, Health Care, with a market value of $6.3 billion. From an investment attractiveness vantage point, ICLR is ranked in the top decile of the sector with a ranking of 31 among the 781 companies in the sector; the stock's Portfolio Grader ranking places it 4 among the 32 companies in this industry group, putting in the top quartile and number 191 in the 5000 company Portfolio Grader company universe.

Currently, Icon Plc (NASDAQ:ICLR) has a Buy using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. ICLR has maintained this ranking for 5 months.

As one of the 785 companies in the GICS Health Care sector Icon Plc (NASDAQ:ICLR) is a component of the 33 company Life Sciences Tools & Services GICS industry group within this sector. ICLR's market value is $6.7 billion which places it in the top half of its industry group. Currently, the stock's Portfolio Grader ranking places it 4 among the 33 companies in this industry group, giving it a well above-average position; among the sector leaders with a ranking of 23 among the 785 companies in the sector, and number 186 in the nearly 5,000 company Portfolio Grader universe.

Currently, Icon Plc (NASDAQ:ICLR) has a Buy using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking ICLR has had from Portfolio Grader for 4 months.

Icon Plc (NASDAQ:ICLR) is one of 33 companies within the Life Sciences Tools & Services GICS industry group, which is in turn part of the 782 company GICS Health Care sector. ICLR has a market value of $6.1 billion which is in the upper half of its industry group. The ranking for ICLR by Portfolio Grader places it 12 among the 33 companies in this industry group, putting it in the second quartile; in the top quartile of the sector with a ranking of 150 among the 782 companies in the sector, and number 1,084 in the nearly 5,000 company Portfolio Grader universe.

The current recommendation of Buy for Icon Plc (NASDAQ:ICLR) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking ICLR has had from Portfolio Grader for 4 months.

Currently, Icon Plc (NASDAQ:ICLR) has a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. ICLR has maintained this ranking for 4 months.

Currently, Icon Plc (NASDAQ:ICLR) has a Buy using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. ICLR has maintained this ranking for 4 months.